MS advocate George Pepper from shift.ms added a patient’s perspective to the discussion on the importance of early intervention in MS.
Health consultant Jean Mossman from the London School of Economics presented an HTA study at EMSP’s 2016 Spring Conference.
Health economist Gisela Kobelt talked about the importance of scientifically backed MS data.
The European Medicines Agency’s (EMA) Isabelle Moulon explains the role of the organisation.
MSIF’s CEO Peer Baneke chaired the panel discussion on paediatric MS at EMSP’s 2016 Spring Conference.
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.